Clinical Trials in Cheongju-si, Chungcheongbugdo [Ch'ungch'ongbuk-do]

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence